Page last updated: 2024-12-06

n-hydroxy-n-isopropyloxamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-hydroxy-N-isopropyloxamate: inhibitor of ketol-acid reductoisomerase; structure given in first source; RN given refers to monopotassium salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23677997
MeSH IDM0177416

Synonyms (7)

Synonym
125568-35-6
n-hydroxy-n-isopropyloxamate
acetic acid, (hydroxy(1-methylethyl)amino)oxo-, monopotassium salt
(hydroxy(1-methylethyl)amino)oxoacetic acid monopotassium salt
potassium;2-[hydroxy(propan-2-yl)amino]-2-oxoacetate
potassium [hydroxy(propan-2-yl)amino](oxo)acetate
DTXSID90925172
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]